Patents by Inventor Scott Tasker

Scott Tasker has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11112401
    Abstract: The invention relates to a method for determining the cell mediated immune competence of a subject. The method comprises conducting a cell-mediated immunoassay (CMI) on a sample comprising immune cells from a subject. The method further comprises detecting in vitro an immune response to a pool of peptides, wherein the pool of peptides is derived from at least three viral antigens.
    Type: Grant
    Filed: March 27, 2017
    Date of Patent: September 7, 2021
    Assignee: Oxford Immunotec Limited
    Inventor: Scott Tasker
  • Patent number: 10295538
    Abstract: The present invention relates to Mycobacterium tuberculosis (M tuberculosis) proteins and immunologically active fragments (peptides or mimotope peptides) thereof. In particular, the invention relates to a group of M. tuberculosis proteins and peptides thereof that are both highly antigenic and characteristic of clinical strains of M. tuberculosis. Accordingly, the further relates to the use of these M. tuberculosis proteins or peptides in diagnosing, treating or preventing M. tuberculosis complex infection.
    Type: Grant
    Filed: August 14, 2015
    Date of Patent: May 21, 2019
    Assignee: Oxford Immunotec Limited
    Inventors: Massimo Amicosante, Ian Durrant, Scott Tasker
  • Publication number: 20190064145
    Abstract: The invention relates to a method for determining the cell mediated immune competence of a subject. The method comprises conducting a cell-mediated immunoassay (CMI) on a sample comprising immune cells from a subject. The method further comprises detecting in vitro an immune response to a pool of peptides, wherein the pool of peptides is derived from at least three viral antigens.
    Type: Application
    Filed: March 27, 2017
    Publication date: February 28, 2019
    Inventor: Scott Tasker
  • Publication number: 20170234871
    Abstract: The present invention relates to Mycobacterium tuberculosis (M tuberculosis) proteins and immunologically active fragments (peptides or mimotope peptides) thereof. In particular, the invention relates to a group of M. tuberculosis proteins and peptides thereof that are both highly antigenic and characteristic of clinical strains of M. tuberculosis. Accordingly, the further relates to the use of these M. tuberculosis proteins or peptides in diagnosing, treating or preventing M. tuberculosis complex infection.
    Type: Application
    Filed: August 14, 2015
    Publication date: August 17, 2017
    Inventors: Massimo Amicosante, Ian Durrant, Scott Tasker